TY - JOUR
T1 - The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer
T2 - A Nationwide Study by the SMARTSHIP Group
AU - Park, Sungmin
AU - Lee, Ji Sung
AU - Yoon, Jae Sun
AU - Kim, Nam Hyoung
AU - Park, Seho
AU - Youn, Hyun Jo
AU - Lee, Jong Won
AU - Lee, Jung Eun
AU - Lee, Jihyoun
AU - Hur, Ho
AU - Jeong, Joon
AU - Kim, Kweon Cheon
AU - Bae, Soo Youn
N1 - Funding Information:
This work was supported by the research grant of the Korean Breast Cancer Society.
Publisher Copyright:
Copyright © 2022 Park, Lee, Yoon, Kim, Park, Youn, Lee, Lee, Lee, Hur, Jeong, Kim and Bae.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - The term ‘pregnancy-associated breast cancer’ is no longer used as it has been consistently reported that breast cancer during pregnancy and breast cancer after delivery (postpartum breast cancer) have different characteristics and prognosis. The purpose of this study is to define postpartum breast cancer by analyzing the incidence rate, related factors, and prognosis according to the timing of breast cancer. Data from the Korean National Health Insurance Service were used to analyze 1,292,727 women aged 20-49 years who birthed their first child between 2007 and 2012. The annual incidence rate of breast cancer after delivery increased every year (7.7 per 10,000 person-years after 5 years, 19.36 per 10,000 person-years after 10 years). The risk of breast cancer was significantly higher (hazard ratio 1.15, 95% CI 1.05-1.27, P=0.0037) in women diagnosed with gestational diabetes, but that was not associated with overall survival (OS). Patients diagnosed with breast cancer within 5 years of delivery had a poorer prognosis than those diagnosed later (5-year OS, <5 years: 91.1% vs. 5-10 years: 96.0%). In multivariate analysis of OS, the hazard ratio of patients diagnosed within 5 years after delivery was twice as high as of patients diagnosed between 5 and 10 years. Women diagnosed with gestational diabetes had an increased risk of breast cancer. Breast cancer patients diagnosed within 5 years of delivery had a poorer prognosis than those diagnosed later. In this regard, careful screening for early diagnosis of high-risk patients and intensive research on new treatment strategies are needed.
AB - The term ‘pregnancy-associated breast cancer’ is no longer used as it has been consistently reported that breast cancer during pregnancy and breast cancer after delivery (postpartum breast cancer) have different characteristics and prognosis. The purpose of this study is to define postpartum breast cancer by analyzing the incidence rate, related factors, and prognosis according to the timing of breast cancer. Data from the Korean National Health Insurance Service were used to analyze 1,292,727 women aged 20-49 years who birthed their first child between 2007 and 2012. The annual incidence rate of breast cancer after delivery increased every year (7.7 per 10,000 person-years after 5 years, 19.36 per 10,000 person-years after 10 years). The risk of breast cancer was significantly higher (hazard ratio 1.15, 95% CI 1.05-1.27, P=0.0037) in women diagnosed with gestational diabetes, but that was not associated with overall survival (OS). Patients diagnosed with breast cancer within 5 years of delivery had a poorer prognosis than those diagnosed later (5-year OS, <5 years: 91.1% vs. 5-10 years: 96.0%). In multivariate analysis of OS, the hazard ratio of patients diagnosed within 5 years after delivery was twice as high as of patients diagnosed between 5 and 10 years. Women diagnosed with gestational diabetes had an increased risk of breast cancer. Breast cancer patients diagnosed within 5 years of delivery had a poorer prognosis than those diagnosed later. In this regard, careful screening for early diagnosis of high-risk patients and intensive research on new treatment strategies are needed.
UR - http://www.scopus.com/inward/record.url?scp=85134256291&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134256291&partnerID=8YFLogxK
U2 - 10.3389/fonc.2022.889433
DO - 10.3389/fonc.2022.889433
M3 - Article
AN - SCOPUS:85134256291
SN - 2234-943X
VL - 12
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 889433
ER -